Connor, Clark & Lunn Investment Management Ltd. Aura Biosciences, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.8 Billion
- Q1 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 71,686 shares of AURA stock, worth $512,554. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,686
Previous 12,922
454.76%
Holding current value
$512,554
Previous $114,000
392.98%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
39.9MCall Options Held
400Put Options Held
1.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$49.5 Million0.5% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$41.5 Million0.73% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.47MShares$31.9 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.68MShares$26.3 Million0.01% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$21.7 Million6.26% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $209M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...